YGEN. Clovis…. Who’s next?21 Dec 2022 18:59
It’s grim out there, that’s for certain. Which makes Avactas current situation and their raise (as in 2020 at peak interest) a moment of strategic brilliance. One thing you have to say for Avacta is they seem to have their eye on the ball in terms of when and how to raise. Yes it hurts at times but this is Aim and we have come off infinitely better than others. We’re in a financially great position going into 2023 and on the cusp of pivotal news (DE with Data is fine by me, or P1b with another DE…. Or any other variant as long as we get the data we’ve been promised). What YGEN shows tonight is how torrid the market conditions are, and I’d say we should all be prepared for the chance AVA6000 does get licensed out. I don’t think that would be the end of the world if it funds our next candidate. Failing that a license deal for 3996, but my point on YGEN is the question of why are we targeting funds and the city boys in feb? Well look at the market. We’re severely undervalued at this point and I think the confusion can be put to bed by the simple fact there isn’t the money out there that there was in 2020/2021, and the city boys pockets are as deep as the funds they manage. This is another shrewd move IMO as it removes the need for PI money should more be required down the line. (Not that I believe it will and I simply believe they’re highlighting a company almost nobody has heard of…. Avacta.).
This is all IMO and I’m sure I’ll get hammered down by some, but I feel we have 3 aces in hand heading into the final trading days of 2022…. Data is the 4th.